Literature DB >> 15646428

Severe acute colitis associated with CMV: a prevalence study.

V Criscuoli1, A Casà, A Orlando, G Pecoraro, L Oliva, M Traina, A Rizzo, M Cottone.   

Abstract

BACKGROUND: Cytomegalovirus has been identified as a pathogen that contributes to flares of colitis when detected in colonic specimens of patients with inflammatory bowel disease. AIM: To determine the overall prevalence and the role of cytomegalovirus infection in a consecutive series of patients with acute severe colitis admitted to our department from 2000 to 2003.
METHODS: Among 42 patients (38 with ulcerative colitis and 4 with Crohn's disease) admitted to our hospital for acute severe colitis, we performed proctoscopy and biopsy together with blood sample for cytomegalovirus determination at the time of admission, regardless of their steroid resistance.
RESULTS: In the 42 patients, we discovered an overall cytomegalovirus infection prevalence of 21.4% (9/42) in our geographical area. In seven patients (16.6%), cytomegalovirus was detected through biopsy. The presence of cytomegalovirus in biopsies was not always predictive of steroid resistance. Three patients with cytomegalovirus in biopsies responded to conventional treatment without needing any antiviral treatment, which suggests that the virus plays only an incidental role.
CONCLUSIONS: Cytomegalovirus is frequently associated with colitis but it is not always pathogenic. Studies on the genotyping of the virus might explain the diversity of its biological behaviour.

Entities:  

Mesh:

Year:  2004        PMID: 15646428     DOI: 10.1016/j.dld.2004.05.013

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  39 in total

1.  Cytomegalovirus in inflammatory bowel disease: A systematic review.

Authors:  Tessa E H Römkens; Geert J Bulte; Loes H C Nissen; Joost P H Drenth
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Cytomegalovirus infection in patients with ulcerative colitis diagnosed by quantitative real-time PCR analysis.

Authors:  Tadayuki Kou; Hiroshi Nakase; Hiroyuki Tamaki; Toyoichiro Kudo; Akiyoshi Nishio; Tsutomu Chiba
Journal:  Dig Dis Sci       Date:  2006-06       Impact factor: 3.199

3.  Cytomegalovirus Colitis, Cytomegalovirus Hepatitis and Systemic Cytomegalovirus Infection: Common Features and Differences.

Authors:  Hiroshi Nakase; Hans Herfarth
Journal:  Inflamm Intest Dis       Date:  2016-01-23

Review 4.  Cytomegalovirus and inflammatory bowel disease: is there a link?

Authors:  Valeria Criscuoli; Maria-Rosa Rizzuto; Mario Cottone
Journal:  World J Gastroenterol       Date:  2006-08-14       Impact factor: 5.742

Review 5.  Management of acute severe ulcerative colitis.

Authors:  Saurabh Kedia; Vineet Ahuja; Rakesh Tandon
Journal:  World J Gastrointest Pathophysiol       Date:  2014-11-15

6.  Cytomegalovirus infection and steroid-refractory inflammatory bowel disease: possible relationship from an updated meta-analysis.

Authors:  Chen-Chen Liu; Shusheng Ji; Yuanyuan Ding; Lili Zhou; Xiangyu Liu; Wen Li
Journal:  Ir J Med Sci       Date:  2018-02-01       Impact factor: 1.568

7.  Assessment of Disease Severity and Role of Cytomegalo Virus Infection in Patients with Ulcerative Colitis.

Authors:  Nobin Babu Kalappurayil; Jino Thomas; Baburajan Mankuni; Varghese Thomas
Journal:  J Clin Diagn Res       Date:  2017-03-01

8.  Clinical significance of cytomegalovirus infection in patients with inflammatory bowel disease.

Authors:  Elena Garrido; Elisa Carrera; Rebeca Manzano; Antonio Lopez-Sanroman
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

9.  Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease.

Authors:  Maha M Maher; Mahmoud I Nassar
Journal:  Dig Dis Sci       Date:  2008-12-18       Impact factor: 3.199

Review 10.  Gastrointestinal cytomegalovirus disease in the immunocompromised patient.

Authors:  Allison L Baroco; Edward C Oldfield
Journal:  Curr Gastroenterol Rep       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.